Ambea AB (publ) (STO:AMBEA)
Sweden · Delayed Price · Currency is SEK 129.10
-0.90 (-0.69%)
At close: Mar 2, 2026
Ambea AB Market Cap
Ambea AB has a market cap or net worth of 10.6 billion as of March 2, 2026. Its market cap has increased by 24.17% in one year.
Market Cap
10.60B
Enterprise Value
23.11B
Revenue
16.04B
Ranking
n/a
PE Ratio
16.30
Stock Price
129.10
Market Cap Chart
Since March 31, 2017, Ambea AB's market cap has increased from 5.58B to 10.60B, an increase of 90.01%. That is a compound annual growth rate of 7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 10.67B | -10.19% |
| Dec 30, 2025 | 11.88B | 46.78% |
| Dec 30, 2024 | 8.10B | 71.86% |
| Dec 29, 2023 | 4.71B | 13.21% |
| Dec 30, 2022 | 4.16B | -27.18% |
| Dec 30, 2021 | 5.71B | -7.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.67B |
| Getinge AB | 55.26B |
| Sectra AB | 37.34B |
| Medicover AB | 32.84B |
| Vimian Group AB | 14.07B |
| Nolato AB | 13.83B |
| Bonesupport Holding AB | 13.51B |
| Vitrolife AB | 12.92B |